Cancer Research UK: Clinical Trial Award
Thursday, 19 Mar 2020
| Funding Deadline
CRUK clinical trial awards support interventional clinical trials of cancer treatment (including systemic treatment, radiotherapy and surgery) with the aim of improving outcome.
The types of studies that fit this scheme are typically:
- Phase 1a/2 dose finding trials testing safety, tolerability and preliminary efficacy (including novel combinations of therapies and radiotherapy, and novel indications)
- Phase 1b/2 or phase 2 trials testing the viability of larger trials, including the ability to recruit and/or to explore tolerability or efficacy of treatments
- Window of opportunity studies
- Phase 2/3 or phase 3 trials to investigate the efficacy, effectiveness and tolerability of interventions with the aim of improving survival.
Deadline for proposals: 19 March 2020
Find out more here